Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Cash from Financing Activities (2016 - 2026)

Iradimed has reported Cash from Financing Activities over the past 14 years, most recently at -$2.6 million for Q1 2026.

  • Quarterly Cash from Financing Activities fell 14.4% to -$2.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$17.9 million through Mar 2026, down 109.11% year-over-year, with the annual reading at -$17.6 million for FY2025, 22.77% down from the prior year.
  • Cash from Financing Activities was -$2.6 million for Q1 2026 at Iradimed, up from -$10.9 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $52341.0 in Q3 2022 and troughed at -$13.3 million in Q1 2023.
  • The 5-year median for Cash from Financing Activities is -$2.2 million (2025), against an average of -$3.6 million.
  • Year-over-year, Cash from Financing Activities tumbled 34536.13% in 2022 and then skyrocketed 71.67% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$198457.0 in 2022, then plummeted by 32.32% to -$262590.0 in 2023, then crashed by 820.64% to -$2.4 million in 2024, then crashed by 349.78% to -$10.9 million in 2025, then skyrocketed by 76.03% to -$2.6 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Cash from Financing Activities are -$2.6 million (Q1 2026), -$10.9 million (Q4 2025), and -$2.2 million (Q3 2025).